SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 47 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,000 | -33.3% | 375 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $3,000 | +200.0% | 375 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $1,000 | – | 375 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 375 | -65.9% | 0.00% | -100.0% |
| Q2 2020 | $1,000 | 0.0% | 1,099 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,000 | – | 1,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WealthTrust Axiom LLC | 11,561 | $11,000 | 0.01% |
| Winslow, Evans & Crocker, Inc. | 586 | $2,000 | 0.00% |
| Stonebridge Financial Planning Group, LLC | 1,099 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,308 | $1,000 | 0.00% |
| US BANCORP \DE\ | 625 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 38 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 29,439 | $29,000 | 0.00% |
| DEUTSCHE BANK AG\ | 24 | $0 | 0.00% |
| CITIGROUP INC | 212 | $0 | 0.00% |